Connect your AI

Evolus EOLS Total Liabilities & Equity

Total Liabilities & Equity at other companies

AbbVieABBV

$136.46B+0.2%

Other financials

Income statement

Revenue$73.1M+6.7%

Gross profit$48.9M+4.8%

Operating income-$6.8M+54.9%

Net income-$10.7M+43.5%

EPS (diluted)-$0.16+46.7%

Balance sheet

Cash & equivalents$49.8M-26.7%

Total debt$164.9M-4.1%

Total equity-$28.8M-336%

Total assets$220.6M+3.4%

Cash flow

Operating cash flow-$10.0M+36.3%

CapEx$415.0K+30.1%

Free cash flow-$10.4M+35.0%

Valuation

Market cap$470.86M-21.3%

Enterprise value$585.97M-16.6%

P/S1.6×-0.6×

Profitability

Gross margin66.1%-2.4pp

Operating margin-13.7%-1.9pp

Net margin-14.4%-3.3pp

FCF margin-9.6%-3.6pp

Returns & leverage

Return on equity-472.6%-1,534pp

Debt / equity22.2×—

Current ratio2×-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evolus's total liabilities & equity?: Evolus (EOLS) reported total liabilities & equity of $220.65M in Q1 2026.
How has Evolus's total liabilities & equity changed year-over-year?: Evolus's total liabilities & equity increased by 3.4% year-over-year, from $213.36M to $220.65M.
What is the long-term trend for Evolus's total liabilities & equity?: Over 5 years (2020 to 2025), Evolus's total liabilities & equity has grown at a 1.6% compound annual growth rate (CAGR), from $209.07M to $225.87M.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.